Genmab — Februar 2016
-
altså relativt ifht de tidligere dage...
-
og Regeneron missede Q4 earnings estimat. Så der er fatisk en grund til deres tab
-
øøøeeehh - kigger i på US?
-
tag lige et kig på US...
-
forhåbentlig ikke i dag - det er noget af det mest fornuftige jeg har set dem gøre i år!
-
feast your eyes on this - http://www.investing.com/indices/nasdaq-biotechnology-components
-
vores udenlandske venner vil ikke rigtigt begynde at købe ind. Mon ikke vi skal have dem med på holdet før vi får vores velfortjente "flush-up"
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind